Short-term follow-up after percutaneous patent ductus arteriosus occlusion between low and high weight pediatric patients: a single center experience

Ni Putu Eka Suwitri; Ni Putu Veny Kartika Yantie; Eka Gunawijaya

doi:10.13181/mji.oa.204154

Authors

Ni Putu Eka Suwitri Department of Child Health, Faculty of Medicine, Universitas Udayana, Integrated Cardiac Service, Sanglah Hospital, Denpasar, Indonesia https://orcid.org/0000-0002-2958-3073
Ni Putu Veny Kartika Yantie Department of Child Health, Faculty of Medicine, Universitas Udayana, Integrated Cardiac Service, Sanglah Hospital, Denpasar, Indonesia https://orcid.org/0000-0002-1381-2572
Eka Gunawijaya Department of Child Health, Faculty of Medicine, Universitas Udayana, Integrated Cardiac Service, Sanglah Hospital, Denpasar, Indonesia

DOI:

https://doi.org/10.13181/mji.oa.204154

Keywords:

catheterization, patent ductus arteriosus, treatment outcome

Abstract

BACKGROUND Device occlusion is a preferred treatment for patent ductus arteriosus (PDA) in adult and children patients; however, the exact limit of body weight requirement has not been established. This study aimed to describe the outcome and safety of transcatheter PDA occlusion in low and high weight pediatric patients.

METHODS This was a retrospective study in Sanglah Hospital, Denpasar, Bali, Indonesia, in patients aged <12 years who had undergone transcatheter PDA occlusions from 2010 to 2017. Data were obtained from the registry including baseline characteristics (age, sex, body weight, and height), procedural-specific data (PDA characteristics, pulmonary and systemic pressures, and flow ratio intra-procedure), and procedural complications. Success rate and adverse events at 24 hours, 1 month, and 3 months after the procedure were assessed.

RESULTS

A total of 175 subjects were grouped into two categories: low weight, ≤6 kg (n = 50) and high weight, >6 kg (n = 125). The success rates (complete closure) in the ≤6 and >6 kg groups were, 90.0% and 75.9% at 24 hours follow-up, 92.9% and 85.5% at 1 month, and 95.8% and 91.1% at 3 months, respectively. Major complications related to the procedure in patients ≤6 kg included transient dysrhythmia (n = 6) and massive bleeding (n = 2), and complications in patients >6 kg were transient dysrhythmia (n = 14), massive bleeding (n = 1), embolization (n = 1), and death (n = 1).

CONCLUSIONS Transcatheter PDA occlusion had similar success rate and safety in both low and high weight pediatric patients.

Downloads

Download data is not yet available.

References

Ali SH, Abdalla SE. Percutaneous transcatheter closure of patent ductus arteriosus: initial experience of Sohag University. Egypt Heart J. 2014;66(2):143-7. https://doi.org/10.1016/j.ehj.2013.01.003

Djer MM, Saputro DD, Putra ST, Idris NS. Transcatheter closure of patent ductus arteriosus: 11 years of clinical experiences in Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Pediatr Cardiol. 2015;36(5):1070-4. https://doi.org/10.1007/s00246-015-1128-2

Wang K, Pan X, Tang Q, Pang Y. Catheterization therapy vs surgical closure in pediatric patients with patent ductus arteriosus: a meta-analysis. Clin Cardiol. 2014;37(3):188-94. https://doi.org/10.1002/clc.22238

Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG, et al. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing <=6 kg. JACC Cardiovasc Interv. 2010;3(12):1295-9. https://doi.org/10.1016/j.jcin.2010.08.022

Kang SL, Morgan G, Forsey J, Tometzki A, Martin R. Long-term clinical experience with amplatzer ductal occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv. 2014;83(7):1102-8. https://doi.org/10.1002/ccd.25393

Djer MM, Mochammading, Said M. Transcatheter vs. surgical closure of patent ductus arteriosus: outcomes and cost analysis. Paediatr Indones. 2013;53(4):239-44. https://doi.org/10.14238/pi53.4.2013.239-44

Baspinar O, Irdem A, Sivasli E, Sahin DA, Kilinc M. Comparison of the efficacy of different-sized amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg. Pediatr Cardiol. 2013;34(1):88-94. https://doi.org/10.1007/s00246-012-0393-6

Wang JK, Wu MH, Lin MT, Chiu SN, Chen CA, Chiu HH. Transcatheter closure of moderate to large patent ductus arteriosus in infants using Amplatzer duct occluder. Circ J. 2010;74(2):361-4. https://doi.org/10.1253/circj.CJ-09-0473

Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis. 2010;5(4):354-65. https://doi.org/10.1111/j.1747-0803.2010.00435.x

Park MK. Invasive Procedure. Park's the pediatric cardiology handbook. 5th ed. Philadelphia: Elsevier; 2016. p. 90-6.

Backes CH, Kennedy KF, Locke M, Cua CL, Ball MK, Fick TA, et al. Transcatheter occlusion of the patent ductus arteriosus in 747 infants <6 kg: insights from the NCDR IMPACT registry. JACC Cardiovasc Intv. 2017;10(17):1729-37. https://doi.org/10.1016/j.jcin.2017.05.018

Backes CH, Rivera BK, Bridge JA, Armstrong AK, Boe BA, Berman DP, et al. Percutaneous patent ductus arteriosus (PDA) closure during infancy: a meta-analysis. Pediatrics. 2017;139:e20162927. https://doi.org/10.1542/peds.2016-2927

El-Said HG, Bratincsak A, Foerster SR, Murphy JJ, Vincent J, Holzer R, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc. 2013;2(6):e000424. https://doi.org/10.1161/JAHA.113.000424

Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK. Transcatheter occlusion of patent ductus arteriosus in preterm infants. JACC Cardiovasc Interv. 2010;3(5):550-5. https://doi.org/10.1016/j.jcin.2010.01.016

Ali SH. Adverse event in pediatric cardiac catheterization: initial experience of Sohag university hospital. Egypt Heart J. 2016;68(1):45-51. https://doi.org/10.1016/j.ehj.2015.06.001

Baruteau A, Hascoët S, Baruteau J, Boudjemline Y, Lambert V, Angel CY, et al. Transchateter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis. 2014;107(2):122-32. https://doi.org/10.1016/j.acvd.2014.01.008